Position in NVO
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$83,287,744
+$34,670,104 QoQ
Shares Held
1,737,333
+31.3% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#37
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 7%
Shared 0%
None 93%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Derivatives in NVO
reported options exposure · as of Dec 31, 2025CallValue
$630,912
CallShares
12,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LPL Financial LLC holds $5,886,151,720 across 17 Drug Manufacturers - General names. NVO ranks #12 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,274,807 | $1,529,041,887 | |
| 2 | JNJ |
Johnson & Johnson
|
5,055,143 | $1,283,854,667 | |
| 3 | ABBV |
AbbVie Inc.
|
4,096,323 | $1,030,798,719 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,836,733 | $493,020,190 | |
| 5 | AMGN |
Amgen Inc
|
1,188,164 | $430,257,947 | |
| 6 | PFE |
Pfizer Inc
|
13,919,821 | $335,189,289 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,265,381 | $188,151,253 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
969,813 | $122,526,174 |
All Filings in NVO
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $83,287,744 | 1,737,333 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $48,617,640 | 1,322,929 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $630,912 | 12,400 | Call | Sole | 2026-02-11 | |
| 2025-12-31 | $62,209,195 | 1,222,665 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $77,660,086 | 1,399,533 | Shares | Sole | 2025-11-12 | |
| 2025-09-30 | $294,097 | 5,300 | Call | Sole | 2025-11-12 | |
| 2025-06-30 | $102,592,639 | 1,486,419 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $95,772,134 | 1,379,207 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $116,648,883 | 1,356,067 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $162,266,452 | 1,362,782 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $187,743,923 | 1,315,286 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $150,820,566 | 1,174,615 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $96,950,339 | 937,171 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $69,191,335 | 760,846 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $48,728,469 | 301,109 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $40,804,769 | 256,408 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $32,668,639 | 241,382 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $23,458,879 | 235,460 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $24,391,804 | 218,898 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $24,391,466 | 219,644 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $24,302,432 | 216,986 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $20,882,559 | 217,504 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $16,033,326 | 191,397 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $11,716,449 | 173,783 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $11,708,606 | 167,625 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $9,362,288 | 134,845 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $7,934,931 | 121,181 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $7,901,852 | 131,260 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||